INVO Fertility Q2 2026 Revenue Up 17%, Clinic Operations Profitable
INVO Fertility reported Q2 2026 revenue growth of 17% and achieved Adjusted EBITDA profitability at the clinic platform level. The financial results signal continued progress in scaling its organically grown and acquired fertility clinic network.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day